Talk:Terfenadine
Page contents not supported in other languages.
Appearance
From Wikipedia, the free encyclopedia
Latest comment: 15 years ago by 74.179.112.79 in topic Controversy Discussion
This article is rated Start-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:
It is of interest to the following WikiProjects:
WikiProject icon This article is within the scope of WikiProject Pharmacology , a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Low This article has been rated as Low-importance on the project's importance scale.
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Terfenadine.
- PubMed provides review articles from the past five years (limit to free review articles )
- The TRIP database provides clinical publications about evidence-based medicine .
- Other potential sources include: Centre for Reviews and Dissemination and CDC
More discussion about the controversy surrounding terfenadine would be nice. I believe that it was this drug that prompted the FDA to enact new rules so drug makers would take into account which CYP enzymes metabolize a candidate drug, so that potential drug-drug (or drug-food) interactions can be anticipated. Could someone put up the narrative story? --74.179.112.79 (talk) 22:24, 10 October 2010 (UTC) Reply